iRhythm Holdings, Inc. IRTC 深 滬
等待開盤 04-02 09:30:00 美东时间
118.22
+0.200
+0.17%
華盛通- 最 高122.31
- 今 開119.79
- 成交量 55.75万股
- 最 低 117.42
- 昨 收 118.02
- 總市值 38.20亿
- 52周最高 212.00
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 97.16
- 委 比 -99.93%
- 總股本 3231.68万
- 歷史最高 286.19
- 量 比 1.02
- 振 幅 4.14%
- 歷史最低 22.25
- 每 手 1
- 風險率 24.99%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Data presented at ACC.26 further demonstrate the benefits of iRhythm’s Zio® ambulatory ECG portfolio across multiple patient populations as company launches new digital education platform
At the ACC.26 meeting, iRhythm Holdings highlighted high rates of actionable arrhythmias in CKM patients using its Zio ECG devices. Also, the company's CMO delivered a keynote on scaling AI in cardiology, and launched the iRhythm Academy for clinician education.
03-30 12:05
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
Citigroup Maintains Buy on iRhythm Holdings, Lowers Price Target to $214
Citigroup analyst Joanne Wuensch maintains iRhythm Holdings (NASDAQ:IRTC) with a Buy and lowers the price target from $242 to $214.
03-11 23:45
iRhythm Chief Accounting Officer Marc Wade Rosenbaum Disposes of Common Shares
iRhythm Chief Accounting Officer Marc Wade Rosenbaum Disposes of Common Shares Marc Wade Rosenbaum, Chief Accounting Officer, reported a disposal of common shares of iRhythm Technologies Inc. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Te
02-26 08:00
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
Where iRhythm Holdings Stands With Analysts
11 analysts have shared their evaluations of iRhythm Holdings (NASDAQ:IRTC) dur...
02-23 22:00
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
Baird Maintains Outperform on iRhythm Holdings, Lowers Price Target to $200
Baird analyst Mike Polark maintains iRhythm Holdings (NASDAQ:IRTC) with a Outperform and lowers the price target from $220 to $200.
02-21 00:59
财报速睇 | iRhythm Holdings, Inc. 2025财年Q4营收2.09亿美元，同比增长27.1%；归母净利润0.06亿美元，扭亏为盈
华盛资讯2月20日讯，iRhythm Holdings, Inc.公布2025财年Q4业绩，公司Q4营收2.09亿美元，同比增长27.1%，归母净利润0.06亿美元，扭亏为盈。
02-20 06:27
BRIEF-iRhythm Technologies Q4 Revenue USD 208.9 Million Vs. IBES Estimate USD 201.6 Million
BRIEF-iRhythm Technologies Q4 Revenue USD 208.9 Million Vs. IBES Estimate USD 201.6 Million Feb 19 (Reuters) - iRhythm Technologies Q4 gross profit USD 148.1 million. Q4 net income USD 5.6 million Q4 gross margin 70.9%
02-20 05:05
